Fig. 1From: Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohortStacked barplot showing Control versus Proton Pump Inhibitor (PPI) groups at species level at the different timepoints. Timepoint 1 (T1) is the baseline condition for PPI treatment; Timepoint 2 (T2) is the end of PPI treatment, and Timepoint 3 (T3) is 1Â month after PPI treatment. Data are divided according to PPI duration, above or below 400Â daysBack to article page